Future technologies in hemapheresis.
Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland 20892.
H G
HG
Klein
D000380:Agranulocytosis / Q000628:therapy; D000818:Animals; D001781:Blood Component Removal / Q000295:instrumentation / Q000379:methods*; D001804:Blood Transfusion, Autologous; D005544:Forecasting; D006133:Growth Substances / Q000494:pharmacology; D006410:Hematopoiesis / Q000187:drug effects; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016219:Immunotherapy, Adoptive; D009369:Neoplasms / Q000628:therapy; D011994:Recombinant Proteins / Q000494:pharmacology
D006133:Growth Substances; D011994:Recombinant Proteins